Impaired Vasoconstriction and Nitric Oxide-Mediated Relaxation in Pulmonary Arteries of Hypoxia- and Monocrotaline-Induced Pulmonary Hypertensive Rats

Pulmonary hypertension (PH) is a life-threatening disease with unclear vascular mechanisms. We tested whether PH involves abnormal pulmonary vasoconstriction and impaired vasodilation. Male Sprague-Dawley rats were exposed to hypoxia (9% O2) for 2 weeks or injected with single dose of monocrotaline (MCT, 60 mg/kg s.c.). Control rats were normoxic or injected with saline. After the hemodynamic measurements were performed, pulmonary and mesenteric arteries were isolated for measurement of vascular function. Hematocrit was elevated in hypoxic rats. Right ventricular systolic pressure and Fulton's Index [right/(left + septum) ventricular weight] were greater in hypoxic and MCT-treated rats than in normoxic rats. Pulmonary artery contraction by phenylephrine and 96 mM KCl was less in hypoxic and MCT-treated rats than in normoxic rats. Acetylcholine-induced relaxation was less in the pulmonary arteries of hypoxic and MCT-treated rats than of normoxic rats, suggesting reduced effects of endothelium-derived vasodilators. The nitric oxide synthase inhibitor, Nω-nitro-l-arginine methyl ester, and the guanylate cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, inhibited acetylcholine relaxation, suggesting that it was mediated by nitric oxide (NO)-cGMP. The NO donor sodium nitroprusside caused less relaxation in the pulmonary arteries of hypoxic and MCT-treated than of normoxic rats, suggesting decreased responsiveness of vascular smooth muscle cells (VSMCs) to vasodilators. Phenylephrine and KCl contraction and acetylcholine and sodium nitroprusside relaxation were not different in the mesenteric arteries from all groups. In lung tissue sections, the wall thickness of pulmonary arterioles was greater in hypoxic and MCT-treated rats than in normoxic rats. The specific reductions in pulmonary, but not systemic, arterial vasoconstriction and vasodilation in hypoxia- and MCT-induced PH are consistent with the possibility of de-differentiation of pulmonary VSMCs to a more proliferative/synthetic and less contractile phenotype in PH.

[1]  F. McGowan,et al.  Divergent Cardiopulmonary Actions of Heme Oxygenase Enzymatic Products in Chronic Hypoxia , 2009, PloS one.

[2]  A. Pries,et al.  Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease* , 2009, Critical care medicine.

[3]  Mario J. Garcia,et al.  Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. , 2009, JACC. Cardiovascular imaging.

[4]  J. Stehlik,et al.  Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. , 2009, Journal of cardiac failure.

[5]  C. Burger Pulmonary Hypertension in COPD: A Review and Consideration of the Role of Arterial Vasodilators , 2009, COPD.

[6]  M. Skokan,et al.  Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[7]  K. Shyu,et al.  Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration. , 2008, Biochemical and biophysical research communications.

[8]  Robin Shandas,et al.  Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves. , 2008, American journal of physiology. Heart and circulatory physiology.

[9]  M. Oka,et al.  Endothelin-1 and Serotonin are Involved in Activation of RhoA/Rho Kinase Signaling in the Chronically Hypoxic Hypertensive Rat Pulmonary Circulation , 2007, Journal of cardiovascular pharmacology.

[10]  S. Barman Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[11]  Kurt R Stenmark,et al.  Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[12]  N. Voelkel,et al.  Rho Kinase-Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in Rats , 2007, Circulation research.

[13]  E. Nozik-Grayck,et al.  Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling. , 2007, Advances in experimental medicine and biology.

[14]  B. Fanburg,et al.  Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells. , 2006, American journal of physiology. Heart and circulatory physiology.

[15]  W. Seeger,et al.  Reversal of experimental pulmonary hypertension by PDGF inhibition. , 2005, The Journal of clinical investigation.

[16]  S. Oparil,et al.  Endothelin-A Receptor Blockade Prevents and Partially Reverses Neonatal Hypoxic Pulmonary Vascular Remodeling , 2005, Pediatric Research.

[17]  G. Ruvolo,et al.  Inhaled Prostacyclin, Nitric Oxide, and Nitroprusside in Pulmonary Hypertension After Mitral Valve Replacement , 2005, Journal of cardiac surgery.

[18]  K. Morris,et al.  Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[19]  R. Budhiraja,et al.  Endothelial Dysfunction in Pulmonary Hypertension , 2004, Circulation.

[20]  W. Seeger,et al.  Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. , 2004, American journal of respiratory and critical care medicine.

[21]  P. D. del Nido,et al.  Hypoxia and Stretch Regulate Intercellular Communication in Vascular Smooth Muscle Cells Through Reactive Oxygen Species Formation , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[22]  M. Yanagisawa,et al.  Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[23]  S. Narumiya,et al.  Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. , 2001, American journal of respiratory and critical care medicine.

[24]  R. Nagai,et al.  Vascular smooth muscle cell phenotypes in primary pulmonary hypertension. , 2001, The European respiratory journal.

[25]  L. Shimoda,et al.  Altered pulmonary vasoreactivity in the chronically hypoxic lung. , 2000, Physiological research.

[26]  D. Beasley,et al.  Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells. , 1999, The American journal of physiology.

[27]  H. Itoh,et al.  Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats. , 1999, European journal of pharmacology.

[28]  M. Ward,et al.  Impaired reactivity of rat aorta to phenylephrine and KCl after prolonged hypoxia: role of the endothelium. , 1998, Journal of applied physiology.

[29]  M. Ward,et al.  Hyporeactivity of rat diaphragmatic arterioles after exposure to hypoxia in vivo. Role of the endothelium. , 1997, American journal of respiratory and critical care medicine.

[30]  C. Hsieh,et al.  Prevention of Hypoxia-Induced Pulmonary Hypertension by Enhancement of Endogenous Heme Oxygenase-1 in the Rat. • 238 , 1997, Pediatric Research.

[31]  R. McIntyre,et al.  Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury. , 1996, Surgery.

[32]  G. Pietra Histopathology of primary pulmonary hypertension. , 1994, Chest.

[33]  J. Piiper,et al.  Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. , 1993, Journal of applied physiology.

[34]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[35]  B. Walker,et al.  Attentuation of systemic vasoreactivity in chronically hypoxic rats. , 1991, The American journal of physiology.

[36]  P. Braquet,et al.  Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. , 1991, The Journal of clinical investigation.

[37]  R. Hopkins,et al.  Pulmonary hypertensive crises following surgery for congenital heart defects in young children. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[38]  B. Groves,et al.  Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. , 1989, Circulation.

[39]  D. Buff Primary pulmonary hypertension. , 1987, Annals of internal medicine.

[40]  M. Gillespie,et al.  Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats. , 1986, The American journal of physiology.